Elucidating a mechanism of mTORC1 activation independent of amino acids signaling
阐明独立于氨基酸信号传导的 mTORC1 激活机制
基本信息
- 批准号:8550755
- 负责人:
- 金额:$ 23.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-30 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenovirusesAffectAgingAlbuminsAllelesAmino AcidsAmino Acids ActivationAutophagocytosisBiogenesisBreedingCalnexinCandidate Disease GeneCategoriesCell LineCellsComplementary DNADiabetes MellitusDiseaseDominant-Negative MutationDown-RegulationEarly EndosomeExcisionFastingGene Expression ProfileGenesGenetically Engineered MouseGolgi ApparatusGrowthGrowth FactorGuanosine Triphosphate PhosphohydrolasesHepatocyteImmunofluorescence ImmunologicImmunoprecipitationInfectionInstitutesLibrariesLiverLysosomesMalignant NeoplasmsMass Spectrum AnalysisMediatingMembraneMembrane Protein TrafficMessenger RNAMolecularMusNull LymphocytesNutrientOrganismPTEN genePathway interactionsPhenotypePhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhysiologyProtein FamilyProtein KinaseProtein Phosphatase 2A Regulatory Subunit PR53Protein phosphataseProteinsProteomicsRNA InterferenceRaptorsRegulationResistanceSeriesSignal PathwaySignal TransductionSirolimusStaining methodStainsStructureSubfamily lentivirinaeSurfaceSystemTSC1/2 geneTechnologyTransgenic MiceTubulinVirusWithdrawalWorkage relatedbasecandidate validationcell growthcostdeprivationdesensitizationembryo cellfallsfeedingfollow-upgenome-widehuman diseaseimmortalized cellimprovedin vivoinhibitor/antagonistknock-downliver infectionmouse modelnovelnovel therapeutic interventionnovel therapeuticsoverexpressionresearch studysmall hairpin RNAstable cell line
项目摘要
DESCRIPTION (provided by applicant): The mechanisms underlying the pro-aging consequences of mTOR activity are obscure. Deregulated mTOR activity leads to accelerated aging and upregulated mTORC1 activity occurs in aging organisms. We recently described the Rag family of proteins as key for mTORC1 activation by amino acids, through a mechanism that requires mTORC1 shuttling to the lysosomal surface. We have generated a series of immortalized cell lines derived from genetically-engineered mice that lack the RagA gene. Although mTORC1 activity is barely detectable in RagA-deficient embryos, cell lines derived from them have reactivated mTORC1 signaling, which is now insensitive to amino acids withdrawal, but sensitive to growth factors withdrawal. Intriguingly, in these lines mTORC1, although active, does not localize to lysosomes, indicating that an additional unknown mechanism of mTORC1 activation is at work. Based on a combination of transcriptional profiling and proteomic-based approaches, we plan to find the genes responsible for the lysosomal-independent activation of mTORC1 and to understand how this occurs. We will then take advantage of RagA-null livers to study in vivo the consequences of altering the expression of the candidates found. Further elucidation of the molecular mechanism leading to mTORC1 desensitization to amino acid withdrawal, together with the identification of druggable targets within this pathway, may pave the way for novel therapeutic approaches to aging and age-related diseases.
描述(由申请人提供):mTOR 活性促衰老后果的机制尚不清楚。 mTOR 活性失调会导致衰老加速,而衰老生物体中 mTORC1 活性上调。我们最近将 Rag 蛋白家族描述为氨基酸激活 mTORC1 的关键,其机制需要 mTORC1 穿梭到溶酶体表面。我们已经产生了一系列源自缺乏 RagA 基因的基因工程小鼠的永生化细胞系。尽管在 RagA 缺陷胚胎中几乎检测不到 mTORC1 活性,但源自它们的细胞系已重新激活 mTORC1 信号传导,该信号现在对氨基酸撤退不敏感,但对生长因子撤退敏感。有趣的是,在这些细胞系中,mTORC1 虽然有活性,但并不定位于溶酶体,这表明 mTORC1 激活的另一个未知机制正在发挥作用。基于转录分析和基于蛋白质组学的方法的结合,我们计划找到负责 mTORC1 溶酶体独立激活的基因,并了解这是如何发生的。然后,我们将利用 RagA 无效的肝脏来研究体内改变所发现的候选者表达的后果。进一步阐明导致 mTORC1 对氨基酸戒断脱敏的分子机制,以及该途径中可药物靶点的鉴定,可能为衰老和年龄相关疾病的新治疗方法铺平道路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David M. Sabatini其他文献
Compositions et procédés pour la modulation de mtorc1
mtorc1 调制的作曲和过程
- DOI:
- 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
David M. Sabatini;Shu Wang;Zhi Tsun - 通讯作者:
Zhi Tsun
MIT Open Access Articles Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR
麻省理工学院开放获取文章 Torin2(一种 mTOR、ATM 和 ATR 的 ATP 竞争性抑制剂)的表征
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Qingsong Liu;Chunxiao Xu;Sivapriya Kirubakaran;Xin Zhang;W. Hur;Yan Liu;Nicholas Kwiatkowski;Jinhua Wang;K. Westover;Peng Gao;D. Ercan;M. Niepel;Carson C. Thoreen;S. A. Kang;M. Patricelli;Yuchuan Wang;T. Tupper;Abigail Altabef;Hidemasa Kawamura;Kathryn D Held;Danny M. Chou;Stephen J. Elledge;P. Janne;Kwok;David M. Sabatini;Nathanael S. Gray - 通讯作者:
Nathanael S. Gray
David M. Sabatini的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David M. Sabatini', 18)}}的其他基金
Novel Components of the mTORC1 and mTORC2 Pathways
mTORC1 和 mTORC2 通路的新成分
- 批准号:
9042919 - 财政年份:2015
- 资助金额:
$ 23.03万 - 项目类别:
Elucidating a mechanism of mTORC1 activation independent of amino acids signaling
阐明独立于氨基酸信号传导的 mTORC1 激活机制
- 批准号:
8443550 - 财政年份:2012
- 资助金额:
$ 23.03万 - 项目类别:
相似国自然基金
肠道菌群对溶瘤腺病毒免疫治疗的影响与机制及综合治疗策略的研究
- 批准号:
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
DENND2D的诱导表达对非小细胞肺癌细胞恶性表型影响及其作用机制研究
- 批准号:81802284
- 批准年份:2018
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
血清4型禽腺病毒3'端135-bp自然缺失影响病毒致病性的研究
- 批准号:31702268
- 批准年份:2017
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
人B组腺病毒纤毛蛋白与DSG2受体亲和力的差异及其对病毒致病力的影响研究
- 批准号:31570163
- 批准年份:2015
- 资助金额:62.0 万元
- 项目类别:面上项目
纤毛杆影响嵌合型腺病毒感染T淋巴细胞效率的机制研究
- 批准号:31400149
- 批准年份:2014
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Pulmonary endothelium targeted adenoviral gene therapy for the correction of mucopolysaccharidosis type I
肺内皮靶向腺病毒基因治疗纠正 I 型粘多糖贮积症
- 批准号:
10678053 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Mechanistic factors limiting utility of adenovirus vectors for treatment of neopla
限制腺病毒载体治疗肿瘤的机制因素
- 批准号:
10618174 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Neural mechanisms preventing postpartum relapse to cocaine seeking in new mothers
防止新妈妈产后复发寻找可卡因的神经机制
- 批准号:
10354553 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Neural mechanisms preventing postpartum relapse to cocaine seeking in new mothers
防止新妈妈产后复发寻找可卡因的神经机制
- 批准号:
10614372 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Viral subversion of intercellular coupling during myocarditis
心肌炎期间细胞间耦合的病毒颠覆
- 批准号:
10522824 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别: